001065.KS
JW Pharmaceutical Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 22,200.00
+1.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 5.99x
- P/E 2027E
- 5.52x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.29x
- PEG TTM
- 0.20x
- Price / book
- 1.31x
- Price / sales
- 0.65x
- Price / cash flow
- 3.99x
Enterprise value
- Enterprise value
- KRW 551.2B
- EV / sales
- 0.67x
- EV / EBITDA
- 4.38x
- EV / EBIT
- 4.82x
- Market cap
- KRW 536.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026